3D Ready Organoid
| Cat No. | C-090 |
| Organism | Human |
| Tissue | Breast |
| Disease | Cancer |
| Growth Properties | Embedded 3D Culture |
| Biosafety Level | 1 |
| Growth conditions | 37℃, 95% Air, 5% CO2 |
| Size/Quantity | 1 |
| Product format | Frozen |
| Shipping Info | Dry Ice |
| Storage conditions | Liquid Nitrogen |
View Product Image
Human Triple Negative Breast Cancer Organoid is a 3D in vitro model derived from patient tumors or established cell lines that lack ER, PR, and HER2 expression. It faithfully recapitulates the aggressive behavior, genetic profile, and heterogeneity of Triple-negative breast cancer, making it a valuable tool for studying tumor biology. It is widely used for drug screening, biomarker discovery, and the development of targeted therapies, particularly for this hard-to-treat breast cancer subtype. Organoids undergo rigorous testing for mycoplasma, bacteria, fungi/yeast, and are verified for identity, genetic stability, and functional performance.
Embedded 3D Culture
All test negative for mycoplasma, bacteria, yeast, and fungi.
For research use only. Human Triple Negative Breast Cancer Organoid is an advanced in vitro model that mimics tumor heterogeneity and microenvironment, enabling studies of cancer development and progression. It is widely used for drug screening and personalized therapy, as well as gene function research through gene editing. Additionally, co-culture systems allow investigation of tumor–microenvironment interactions.
Whether you're exploring disease mechanisms or screening novel therapeutics, OgCelix is your trusted partner.
Let's build the future of translational research together.
Whether you're exploring disease mechanisms or screening novel therapeutics, OgCelix is your trusted partner.
Let's build the future of translational research together.
